In addition, Lactate dehydrogenase (LDH) inhibition by oxamate induced G2/M cell cycle arrest via downregulation of the CDK1/cyclin B1 pathway might serve as a promising therapeutic target for NPC treatment [23]. This evidence concerns the gene CDK1 and nasopharyngeal carcinoma.